Objectives Our primary objective was to quantify damage burden measured by Damage
Index for Antiphospholipid Syndrome (DIAPS) in aPL-positive patients with or without a …

Objective To analyse the association between the average 'adjusted'Global APS Score
(aGAPSS) over time, as a surrogate of disease activity, and change in Damage Index for …

OBJECTIVES: To determine whether early damage and its kinetics measured by the
Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality. METHODS: We …

Background Antiphospholipid syndrome (APS) is an acquired thrombophilia that affects
young productive individuals, with permanent damage and negative impact on quality of life …

Abstract Purpose of Review Laboratory criteria for the classification of antiphospholipid
syndrome include the detection of a lupus anticoagulant and/or anticardiolipin and anti-β2 …

Background Despite anticoagulant therapy, a antiphospholipid syndrome (APS) has a
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …

We read with great interest the article by Grika, et al, a retrospective analysis of the
morbidity, mortality, and organ damage in patients with antiphospholipid syndrome (APS) …

Background The antiphospholipid syndrome is an autoimmune-acquired thrombophilia, the
thrombotic manifestations are associated with an important risk of organ damage. 1 A new …

Objective This study assessed patient‐reported outcomes (PROs) in individuals with
persistently positive antiphospholipid antibodies (aPL) to better understand how living with …

Antiphospholipid syndrome (APS) affects young patients in the most productive years of their
life, and the consequences of organic or tissue damage involve a decrease in health-related …